ClinicalTrials.govpublic full text
Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
ovarian neoplasms, immunotherapy, monoclonal, antibody, stage iii ovarian epithelial cancer, stage iv ovarian epithelial cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851165
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.